Poster Session 4
Emily Schneider, MD (she/her/hers)
NYU Grossman Long Island School of Medicine
Mineola, New York, United States
Dajana Alku, MD
NYU Grossman Long Island School of Medicine
Mineola, New York, United States
Amberly Lao, MD
NYU Grossman Long Island School of Medicine
Mineola, New York, United States
Delphina Maldonado, BA
NYU Langone Hospital
Long Island, New York, United States
Emma Walker
NYU Grossman Long Island School of Medicine
Mineola, New York, United States
Xiwei Yang
NYU Langone Hospital - Long Island
Mineola, New York, United States
Martin Chavez, MD (he/him/his)
Professor of Obstetrics, Gynecology & Reproductive Medicine
NYU Langone Hospital
New York, New York, United States
Hye Heo, MD
NYU Langone Hospital
Long Island, New York, United States
To determine if trial of labor in term pregnancies with fetal growth restriction (FGR) impacts neonatal morbidity compared to planned Cesarean delivery.
In pregnancies with term FGR, there was no difference in composite neonatal morbidity in those undergoing TOL versus planned CD. Subgroup analyses for severe FGR, FGR based on AC < 10%, oligohydramnios, and abnormal fetal Dopplers showed no difference in composite neonatal morbidity. Of those with term FGR undergoing TOL, 78.7% had a VD without significantly increased neonatal morbidity or delivery complications. These findings support a trial of labor for patients with FGR at term.